| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |